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of androgen-sensitive diseases, espe-
cially acne and seborrhea.
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TO THE EDITOR
Intrinsic and UV-induced human skin
aging involves a number of changes,
including reduced epidermal prolifera-
tion, impaired melanocyte function,
and decreased collagen biosynthesis
(Yaar et al., 2002; McCullough and
Kelly, 2006). To ameliorate or inhibit
these effects it is important to identify
the principal factors that influence skin
aging.
Reduced stem cell abundance or self-
renewal ability is a feature of aging in a
number of different tissues (Flores et al.,Abbreviations: MCSP, melanoma chondroitin sulfate proteoglycan
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Figure 1. Age-related changes in epidermal structure. (a) Clustering of tissue donor age. (b) Assessment criteria for epidermal thickness (red), rete ridge
(RR) height (blue), and basal cell density (purple cells). (c–e) Representative hematoxylin and eosin stained skin sections from each age group. (f–h)
Quantification of epidermal thickness (f), RR height (g), and basal cell density (h) in all 21- to 33- (black), 51- to 59- (red), and over 60-year-old samples (blue).
Bars¼ 100 mm. Error bars represent SEM. Significance was assessed both by unpaired t-test and one-way ANOVA in conjunction with post-test trend
analysis (***Po0.0001; **Po0.005).
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2005; Rando, 2006; Sharpless and
DePinho, 2007; Rossi et al., 2008).
Nevertheless, when we examined young
and intrinsically aged murine skin (Gian-
greco et al., 2008), we found that
despite alterations in epidermal prolif-
eration, dermal thickness, and periph-
eral T cells, the abundance of CD34-
positive epidermal stem cells did not
decline with increasing age. Further-
more, young and aged murine epider-
mal stem cells have similar in vitro
growth and differentiation potential
(Stern and Bickenbach, 2007). These
findings suggest that murine epidermal
stem cells may be unaffected by intrinsic
skin aging (Giangreco et al., 2008).
We have now examined whether
expression of epidermal stem cell mar-
kers changes during aging of human
skin. We examined frozen sections of
abdominal skin from 23 Caucasian
donors (22 female and 1 male), three
of whom were recently deceased.
Tissue was obtained in compliance
with the relevant European Union and
United Kingdom regulations. Cadaveric
skin samples were obtained with the
approval of the Anatomy Department,
University of Glasgow, UK. Other
samples were obtained from Biopredic
International, Rennes, France. Helsinki
principles were adhered to and partici-
pants gave written, informed consent to
provide samples for research. The ages
of the donors were non-uniformly dis-
tributed and instead clustered into three
distinct groups, as shown in Figure 1a.
The youngest age group ranged from 21
to 33 years (average age 30.5±1.1
years; n¼10). The intermediate group
was aged 51–59 years (average 53.1±
1.0 years; n¼7). The oldest group was
over 60 years (average 68.5±2.8 years;
n¼6). Immunostaining revealed a low
level of epidermal p53 expression,
indicating that the skin had not been
subject to significant sun exposure
(Tyrrell, 1996), except for two skin
samples in the youngest age group (data
not shown).
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Figure 2. Age-related changes in proliferation and stem cell markers. (a–c) Representative tissue sections from each age group stained for b1 integrins (red)
with 40,6-diamidino-2-phenylindole (DAPI) nuclear counterstain (green). (d) The level of anti-b1 integrin fluorescence at cell–cell borders in the epidermal
basal layer was measured essentially as described previously (Mole`s and Watt, 1997). Colored traces correspond to lines in micrograph. (e) b1 integrin
fluorescence (pixel intensity; arbitrary units (AU)) per basal layer cell border was determined in all samples. Each asterisk indicates significant difference in pixel
intensity relative to other age groups. (f–h) Representative tissue sections from each age group were stained with anti-MCSP (red) with DAPI nuclear counterstain
(green). (i) The number of MCSP-positive basal cells was determined as a function of basement membrane length. (j–m) Ki67 immunostaining (red) with DAPI
nuclear counterstain (blue) of representative sections from each age group. (m) Number of Ki67-positive cells per 100mm basement membrane. White lines
denote basement membrane (a–c, g–h, j–l). Bars¼ 100 mm. Error bars represent SEM. Significance was assessed by unpaired t-test and one-way ANOVA in
conjunction with post-test trend analysis (***Po0.0001; *Po0.05). ITGB1, b1 integrin; MCSP, melanoma chondroitin sulfate proteoglycan.
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We measured rete ridge height,
epidermal thickness, and basal cell
density in haematoxylin and eosin
stained sections (Figure 1b–e). Consis-
tent with earlier reports of skin aging
(Makrantonaki and Zouboulis, 2007),
subjects within over 60-year-old group
exhibited increased inter-individual
variability in all measurements relative
to both 21- to 33- and 51- to 59-year-
old subjects (see Figures 1f–h and 2m).
There were no statistically significant
differences in epidermal thickness
between the different age groups
(Figure 1f). However, both the 51- to
59-year-old group and the over
60-year-old group exhibited signifi-
cantly reduced rete ridge height relative
to the youngest group, as assessed by
both unpaired t-test (Po0.005) and
one-way ANOVA post-test trend
analyses (Po0.0001; Figure 1g).
There was also a statistically significant
reduction in basal cell density when
the oldest group was compared
with the other two groups (Po0.005;
Figure 1h).
Two markers of human interfol-
licular epidermal stem cells are mela-
noma chondroitin sulfate proteoglycan
(MCSP; NG2; Legg et al., 2003) and
high levels of b1 integrins (Jones and
Watt, 1993; Jones et al., 1995; Jensen
et al., 1999). Frozen skin sections were
labeled with anti-b1 integrin antibo-
dies, and the fluorescence pixel inten-
sity of lateral cell borders in the basal
epidermal layer was quantified (Jones
et al., 1995; Mole`s and Watt, 1997)
(Figure 2a–e). In the skin samples of
21- to 33-year-old subjects, the cells with
highest b1 integrin levels tended to lie
at the tops of the rete ridges (Figure 2a),
as reported previously (Jones et al.,
1995). Although the modal pixel
intensity values for all age groups were
similar, the mean and median values
decreased with age (Figure 2e). In the
21- to 33-year-old group, the mean was
143 arbitrary units and the median was
132. The 51- to 59-year-old group had
a mean of 139 and median of 120. In
the over 60-year-old group the mean
was 103 and the median was 102. In
addition, the lowest pixel intensity values
were only found in the over 60-year-old
group (Figure 2e). A similar reduction
in integrin expression has been observed
in chronically UV-exposed skin (Bosset
et al., 2003).
MCSP expression is confined to
discrete clusters of cells, corresponding
to the cells that express the highest b1
integrin levels (Legg et al., 2003) (Figure
2f). MCSP-positive cluster size was
similar in the 21- to 33- and 51- to
59-year-old groups; however, one-way
ANOVA analysis indicated a significant
decline in the oldest sample group
(Po0.0001; Figure 2f–i).
We also stained frozen skin sections
with antibodies to Ki67 as a marker of
proliferation (Figure 2j–l). There was a
statistically significant increase in Ki67-
positive cells in the 51- to 59-year-old
group relative to the 21- to 33-year-old
group (Po0.05; Figure 2m), and a
reduced tendency for Ki67-positive
cells to cluster in the rete ridges (Figure
2j and k). There was no statistically
significant difference in Ki67 abun-
dance between the oldest samples and
the other groups; however, there was a
large spread in values within the over
60-year-old samples (Figure 2m).
We have previously reported that
cells with the highest in vitro self-
renewal capacity express MCSP and
high b1 integrin levels (Jones and Watt,
1993; Jones et al., 1995; Legg et al.,
2003). Our current findings are there-
fore consistent with the earlier report
that significantly aged human epider-
mal cells exhibit reduced in vitro
self-renewal ability (Barrandon and
Green, 1987). The reduction in b1
integrin levels and MCSP expression
with advancing age may also contribute
to age-associated changes in dermal
thickness and skin vascularization. In-
tegrins collaborate with growth factor
receptors to influence growth factor
production and responsiveness (Legate
et al., 2009; Streuli and Akhtar,
2009), and MCSP can enhance integ-
rin-dependent signaling (Yang et al.,
2004). It will now be of interest to
determine whether restoration of b1
integrin levels might reverse some
aspects of normal human skin aging.
Overall, our studies provide evidence
of previously unappreciated molecular
changes that occur before the skin
alterations most typically seen after 70
years of age (Makrantonaki and Zou-
boulis, 2007).
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Dermal Nitrite Application Enhances Global
Nitric Oxide Availability: New Therapeutic Potential
for Immunomodulation?
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TO THE EDITOR
Systemic administration of nitrite (NO2
)
affords protection against ischemia/
reperfusion-related organ damage
(Lundberg et al., 2008), whereas topical
nitrite application exerts local antimi-
crobial effects and promotes wound
healing (Weller et al., 2001; Weller
and Finnen, 2006). The latter two
actions require acidification, are often
accompanied by increased blood flow
(Tucker et al., 1999; Gribbe et al.,
2008), and are thought to be mediated
by the formation of nitric oxide (NO),
albeit not all effects of nitrite necessa-
rily occur through NO generation
(Bryan et al., 2005). Although the
significance of NO in cutaneous phy-
siology is widely recognized (Bruch-
Gerharz et al., 1998; Weller, 2003), the
relevance and biological function of its
oxidation product, nitrite, are incom-
pletely understood (Suschek et al.,
2006), as is the mechanism by which
dermal nitrite couples to systemic NO/
nitrite physiology.
Nitrite concentrations in human skin
are considerably higher than those in
circulation (Paunel et al., 2005; Mow-
bray et al., 2009) and are a reflection of
local NO synthase activity. Nitrite is
also a constituent of human sweat,
possibly produced via reduction of
nitrate by commensal heterotrophic
bacteria colonizing the skin (Weller
et al., 1996). The actions of nitrite in
or on the skin have been proposed to
contribute to host defense against skin
pathogens and include modulation of
cutaneous T-cell function, keratinocyte
differentiation, blood flow, and protec-
tion against UV-radiation damage
(Weller et al., 1996; Suschek et al.,
2006). Whether these actions of nitrite
extend beyond the skin is unknown.
Recently, nitrite production via auto-
trophic oxidation of ammonia by der-
mal microflora has been proposed to
contribute to bodily NO status and
immune system function (Whitlock
and Feelisch, 2009). An important
prerequisite for the validity of this
concept is nitrite’s ability to permeate
the skin. Although substances with a
molecular weight of o500 Da are be-
lieved to cross the stratum corneum with
ease (Bos and Meinardi, 2000), the same
rules may not apply for negatively char-
ged ions (nitrous acid (HNO2) has a pKa
of 3.4 and is thus largely (499.9%)
dissociated at physiological pH; Butler
and Ridd, 2004). Apart from anecdotal
evidence of fatal methemoglobinemia
after application of a liniment containing
large quantities of nitrite (Saito et al.,
1996, 1997), no information on dermal
nitrite uptake is available. We therefore
sought to investigate, using a rodent
model, whether nitrite permeates the
skin to reach internal organs through
the circulation.
Pharmacologically relevant doses of
nitrite (0.1, 1.0, and 10 mg kg1 in
phosphate-buffered saline; pH 7.4) or
vehicle were topically applied in equal
volumes (800 ml) to a shaved area of
dorsal skin, and concentrations of
several NO-related metabolites (nitrite,
nitrate, S- and N-nitroso compounds
(RXNO), and NO-heme species) were
determined simultaneously in multiple
compartments using extensively validated
ion-chromatographic and gas-phase
chemiluminescence-based techniques
(Feelisch et al., 2002; Rodriguez et al.,
2003; Bryan et al., 2004) (see Supple-
mentary Materials for details). We find
(i) that no acidification is required to
increase NO-related metabolites in
blood and tissues and (ii) that compart-
ments in which increases occur include
those important for priming and func-
tional modulation of immune cellsAbbreviations: NO, nitric oxide; RXNO, S- and N-nitroso compounds
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